Cargando…

Deficiency of the X-inactivation escaping gene KDM5C in clear cell renal cell carcinoma promotes tumorigenicity by reprogramming glycogen metabolism and inhibiting ferroptosis

Background: Clear cell renal cell carcinoma (ccRCC) is characterized by glycogen-laden, unexplained male predominance, and frequent mutations in the Von Hippel-Lindau (VHL) gene and histone modifier genes. Besides, poor survival rates of ccRCC patients seem to be associated with up-regulation of the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zheng, Qian, Li, Pengfei, Zhou, Xin, Qiang, Yulong, Fan, Jiachen, Lin, Yan, Chen, Yurou, Guo, Jing, Wang, Fan, Xue, Haihua, Xiong, Jie, Li, Feng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2021
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8419058/ https://www.ncbi.nlm.nih.gov/pubmed/34522206 http://dx.doi.org/10.7150/thno.60233

Ejemplares similares

Glycogen-rich clear cell carcinoma of the breast
por: Markopoulos, Christos, et al.
Publicado: (2008)

Immunophenotypes of Glycogen Rich Clear Cell Carcinoma
por: Kim, Sung Eun, et al.
Publicado: (2012)

Histone demethylase KDM3B protects against ferroptosis by upregulating SLC7A11
por: Wang, Yishu, et al.
Publicado: (2020)

Tumorigenic potential is restored during differentiation in fusion-reprogrammed cancer cells
por: Yao, J, et al.
Publicado: (2016)

Escape from X inactivation in mice and humans
por: Berletch, Joel B, et al.
Publicado: (2010)

Scutellaria barbata Inhibits Hepatocellular Carcinoma Tumorigenicity by Inducing Ferroptosis of Hepatocellular Carcinoma Cells
por: Li, Yue, et al.
Publicado: (2022)

Significance of KDM6A mutation in bladder cancer immune escape
por: Chen, Xingxing, et al.
Publicado: (2021)

KDM3 epigenetically controls tumorigenic potentials of human colorectal cancer stem cells through Wnt/β-catenin signalling
por: Li, Jiong, et al.
Publicado: (2017)

Loss of chromosome Y leads to down regulation of KDM5D and KDM6C epigenetic modifiers in clear cell renal cell carcinoma
por: Arseneault, Madeleine, et al.
Publicado: (2017)

Regulation of KDM5C stability and enhancer reprogramming in breast cancer
por: Xiao, Qiong, et al.
Publicado: (2022)

Glycogen metabolism is dispensable for tumor progression in clear cell renal cell carcinoma
por: Xie, Hong, et al.
Publicado: (2021)

Glucose metabolism reprogramming promotes immune escape of hepatocellular carcinoma cells
por: Zhang, Qiuyue, et al.
Publicado: (2023)

Histone demethylase KDM6B has an anti-tumorigenic function in neuroblastoma by promoting differentiation
por: Yang, Liqun, et al.
Publicado: (2019)

A PRC2-Kdm5b axis sustains tumorigenicity of acute myeloid leukemia
por: Ren, Zhihong, et al.
Publicado: (2022)

Escape from X Inactivation Varies in Mouse Tissues
por: Berletch, Joel B., et al.
Publicado: (2015)

Metabolic reprogramming of clear cell renal cell carcinoma
por: Zhu, Haiyan, et al.
Publicado: (2023)

Tumorigenic Cell Reprogramming and Cancer Plasticity: Interplay between Signaling, Microenvironment, and Epigenetics
por: Poli, Vittoria, et al.
Publicado: (2018)

Histone demethylase KDM4B contributes to advanced clear cell renal carcinoma and association with copy number variations and cell cycle progression
por: Tang, Heting, et al.
Publicado: (2023)

Deletion of Glycogen Synthase Kinase 3 Beta Reprograms NK Cell Metabolism
por: Pereira, Marcelo S. F., et al.
Publicado: (2023)

Author Correction: KDM3 epigenetically controls tumorigenic potentials of human colorectal cancer stem cells through Wnt/β-catenin signalling
por: Li, Jiong, et al.
Publicado: (2019)

Mechanism of glycogen synthase inactivation and interaction with glycogenin
por: Marr, Laura, et al.
Publicado: (2022)

An Unusual Case of Locally Advanced Glycogen-Rich Clear Cell Carcinoma of the Breast
por: Martín-Martín, Beatriz, et al.
Publicado: (2011)

Abstract QS51: Skeletal Muscle Regeneration by Fibromodulin Reprogrammed Cells without Tumorigenic Risks
por: Ha, Pin, et al.
Publicado: (2018)

Targeted inhibition of KDM6 histone demethylases eradicates tumor-initiating cells via enhancer reprogramming in colorectal cancer
por: Zhang, Junbao, et al.
Publicado: (2020)

UTX is an escape from X-inactivation tumor-suppressor in B cell lymphoma
por: Li, Xiaoxi, et al.
Publicado: (2018)

Glycogen rich clear cell carcinoma of the breast: a rare subtype with good prognosis
por: Al-Musaifer, Budoor Mohamed, et al.
Publicado: (2019)

Clear Cell Adenocarcinoma of the Urinary Bladder Is a Glycogen-Rich Tumor with Poorer Prognosis
por: Zhou, Zhengqiu, et al.
Publicado: (2020)

Analysis of Ferroptosis-Related Gene Expression and Prognostic Factors of Renal Clear Cell Carcinoma Based on TCGA Database
por: Ma, Sijia, et al.
Publicado: (2021)

KDM6B drives epigenetic reprogramming associated with lymphoid stromal cell early commitment and immune properties
por: Sylvestre, Marvin, et al.
Publicado: (2023)

UHRF1 inhibition epigenetically reprograms cancer stem cells to suppress the tumorigenic phenotype of hepatocellular carcinoma
por: Wang, Yanchen, et al.
Publicado: (2023)

Inactivation of the WASF3 gene in prostate cancer cells leads to suppression of tumorigenicity and metastases
por: Teng, Y, et al.
Publicado: (2010)

Reprogramming of iron metabolism confers ferroptosis resistance in ECM-detached cells
por: He, Jianping, et al.
Publicado: (2023)

Aberrant expression of KDM1A inhibits ferroptosis of lung cancer cells through up-regulating c-Myc
por: Lu, Can, et al.
Publicado: (2022)

Inactivation of the phosphoglucomutase gene pgm in Corynebacterium glutamicum affects cell shape and glycogen metabolism
por: Seibold, Gerd M., et al.
Publicado: (2013)

Mitochondrial reprogramming in peripheral blood mononuclear cells of patients with glycogen storage disease type Ia
por: Rossi, Alessandro, et al.
Publicado: (2023)

Escape from self: Stress increase consumers' preference for experiences over material possessions
por: Zhao, Yurou, et al.
Publicado: (2023)

Elevated ATGL in colon cancer cells and cancer stem cells promotes metabolic and tumorigenic reprogramming reinforced by obesity
por: Iftikhar, Rida, et al.
Publicado: (2021)

Glycogen Rich Clear Cell Carcinoma (GRCC) of the breast may not have a poor prognosis
por: Baslaim, Muna M., et al.
Publicado: (2017)

The different expression of glycogen phosphorylases in renal clear cell renal carcinoma and chromophobe renal carcinoma
por: Lu, Yang, et al.
Publicado: (2020)

X Inactivation and Escape: Epigenetic and Structural Features
por: Fang, He, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_n46m45mrqgbufigdbqoq7im8rq